Results

Total Results: over 10,000 records

Showing results for "treatments".

481. Overtreatment in the United States. | PSNet
     psnet.ahrq.gov/issue/overtreatment-united-states
     November 21, 2017 - September 2, 2015 Assessment of overuse of medical tests and treatments at US hospitals … Development of a conceptual map of negative consequences for patients of overuse of medical tests and treatments

482. Quantitative Synthesis: Chapter 5. Network Meta-Analysis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-5.pdf
     February 01, 2018 - . ► This leaves patients and clinicians largely unable to directly compare across treatments • Network … • Inconsistency may be due to several factors, including: differences in patients, treatments, settings … Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many … • Cautiously use inference based on the rankings and probabilities of treatments being most effective … Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many

483. Overdiagnosis in primary care: framing the problem and finding solutions. | PSNet
     psnet.ahrq.gov/issue/overdiagnosis-primary-care-framing-problem-and-finding-solutions
     November 01, 2017 - screenings, clarifying the definition of overdiagnosis, and adjusting cultural expectations for testing and treatment … November 1, 2017 To expand the evidence base about harms from tests and treatments. … Development of a conceptual map of negative consequences for patients of overuse of medical tests and treatments

484. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
     July 01, 2010 - What are the associated risks, adverse effects, and potential harms of nonoperative and operative therapies … versus physical therapy alone. … Aquatic therapy with land-based therapy vs. … treatment Shock-wave therapy vs. mini-open RCR (n=1) Low The evidence was too limited to make a conclusion … Physical therapy treatment, oral medication, Low The evidence was too limited to make a conclusion. and

485. Infantile-Hemangioma Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
     January 01, 2016 - success Nonressolution of lesions Adjuvant or replacement therapies or agents KQ2 KQ3 5 … These 148 studies included 42 comparative studies, 38 addressing effectiveness and harms of therapies … therapy is more effective than propranolol alone. … Effectiveness and Harms of Second-Line Therapies Following Beta-Blockers or Corticosteroids We did … since the advent of beta-blocker treatment in countries, like the United States, where such treatments

486. Menopause Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
     March 01, 2015 - treatment are recommended. … Summary of long-term effects of menopausal hormone therapy preparations Outcome Risk Treatment vs. … Summary of long-term effects of nonhormone therapy preparations Outcome Risk Treatment vs. … , 2 for nonhormone prescription therapies, and 4 for nonprescription therapies. … • Millions of women use compounded hormone treatments.

487. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , reduce complications of therapy, and allow patients to initiate therapy sooner, which could slow …  Key Facts: Current therapies for CF have improved median survival times, but patients with CF … therapy, and chest therapy, if the drug halts disease progression. … United Therapeutics products. [internet].

488. TeamSTEPPS in long-term care- an academic partnership: part 1 and part 2. | PSNet
     psnet.ahrq.gov/issue/teamstepps-long-term-care-academic-partnership-part-1-and-part-2
     July 05, 2017 - October 9, 2024 Clinicians' expectations of the benefits and harms of treatments, screening … May 17, 2023 Patients' expectations of the benefits and harms of treatments, screening

489. Kidney-Stone-Prevention Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-prevention_research-protocol.pdf
     June 15, 2011 - Based on internal discussions and input from the Technical Expert Panel (TEP), additional therapeutic … KQs 2 and 3 for dietary therapies and KQs 4 and 5 for pharmacological therapies) … (see KQs 2 and 3 for dietary therapies and KQs 4 and 5 for pharmacological therapies). … o KQs 4 and 5: – No treatment, usual care, placebo, dietary therapy, other pharmacological therapy … For all treatments, subgroup analyses that will be performed if feasible include evaluation of treatment

490. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49668/psn-pdf
     October 01, 2012 - treatments (including length of abstinence following treatment), and other comorbid medical and mental … Psychosocial treatment modalities, including group, individual, and family therapy, are equally important … and employ evidence-based treatment approaches such as motivational enhancement therapy, cognitive- … behavioral therapy, 12-Step programs, and/or contingency management therapy. … Patients who drop out of psychosocial treatments need to be reevaluated for continued opioid therapy.

491. Disposition of Comments Report for Recurrent Nephrolithiasis in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
     July 26, 2012 - A search for molecular markers that will help tailor therapy is needed. … We agree that future research should investigate novel therapies to prevent recurrence of calcium oxalate … use of unnecessary and/or ineffective therapies in asymptomatic patients that may result in treatment … Previous systematic reviews of randomized controlled trials (RCTs) of dietary and pharmacological therapies … medical strategies was to determine the efficacy and adverse effects of dietary and pharmacologic therapies

492. Spotlight Case July 2008 (ppt file)
     psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.224_slideshow.ppt
     October 01, 2010 - Prevalence of Errors One retrospective study found 1 error or adverse event for every 733 dialysis treatments … A typical center does 500 treatments per week In a national survey of dialysis center staff, 87% acknowledged … a mistake or error in a dialysis treatment in the last 3 months See Notes for references … dialyzers Staff education Avoiding reuse in patients with infectious diseases Staggering dialysis treatments … Characteristics and treatment of patients not reusing dialyzers in reuse units.

493. Recommendation: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/autism-spectrum-disorder-in-young-children-screening
     February 16, 2016 - Treatment and Interventions Treatments for ASD include behavioral, medical, educational, speech/language … , and occupational therapy and complementary and alternative medicine approaches. … Treatments and Interventions Treatments for ASD include behavioral, medical, educational, speech/language … , and occupational therapy and complementary and alternative medicine approaches. … Treatment could be compared with a wait-list control, less intense treatment, or an alternative treatment

494. Final Research Plan: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication
     February 08, 2018 - other than newborns Interventions Ocular prophylaxis for gonococcal ophthalmia neonatorum Treatments … other than ocular prophylaxis Comparisons KQ 1: No treatment, placebo (randomized, controlled … trials) KQ 2: No treatment (randomized, controlled trials) or no comparator (observational studies … quality Fair- or good-quality studies Poor-quality studies * Comparative effectiveness of treatments

495. Implementation Guide: Factors to Consider in Managing Chronic Pain (pdf file)
     cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
     January 01, 2024 - treatment decisions. … nonopioid pharmacologic therapy for the treatment of pain, as well as additional complex factors to … Intervention “Nonopioid pain medication” Medications with analgesic effects that may provide therapeutic … ” Nonmedication procedures and therapies employed to treat pain (e.g., physical therapy, massage, … updated in 2023, with several therapies now showing evidence of benefit in the 2022 AHRQ systematic

496. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49762/psn-pdf
     June 01, 2016 - List the characteristics of Physician Orders for Life-Sustaining Treatments (POLST) forms. … The resident stated the patient had completed a POLST form (Physician Orders for Life-Sustaining Therapy … In discussions with the family, all agreed the patient would not want ongoing aggressive therapy. … Physician Orders for Life-Sustaining Treatment (POLST) forms were developed to overcome these (and other … (e.g., CPR and life-sustaining treatment).

497. Archived: Final Evidence Summary: Dental Caries in Children from Birth Through Age 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary2/dental-caries-in-children-from-birth-through-age-5-years-screening-2014
     June 15, 2013 - Approximately three-quarters of children with caries have not received treatment 5 . … For preventive treatments (key question 6), we also included studies of primary care–feasible treatments … Topical antimicrobial therapy in the prevention of early childhood caries: a follow-up report. … groups A: One 5% fluoride varnish treatment and 2 placebo treatments every 6 mo B: One set of … 3.5% fluoride varnish treatments over 2 wk once per year and 3 placebo treatments over 2 wk, 6 mo later

498. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Following diagnosis, the patient is directed to treatments for AD or treatments for a number of other … clinical patient management, other than the potential for initiating patients on symptom-targeted therapy … , once treatment has begun.

499. CDS Artifact Enhancement Based on Pilot Implementation. Factors to Consider in Managing Chronic Pain: (pdf file)
     cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
     December 01, 2018 - (e.g., completed treatments, an order for cancer treatment) is not available in their system. … CDC recommendations include the need to evaluate for risk factors prior to initiating opioid therapy … section of the Summary to assist clinicians in managing constipation, a common side effect of opioid therapy … For instance, the treatment itself (e.g., physical therapy, yoga) does not occur in a primary care … and treatments rarely occur in a primary care setting; therefore, evidence of the treatment being performed

500. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - LDL-c levels are indications for the initiation of treatment and represent therapeutic targets, but these … Treatment options for individuals requiring intensive lipid-modifying therapy include increasing the … Substantially more information was available for statin- ezetimibe combination therapy in which the treatment … In 88 percent of 18 trials conducted in a population in need of intensive treatment, combination therapy … Studies generally employed therapeutic doses of interventions, but few compared the addition of another